tiprankstipranks
Trending News
More News >
EyePoint Pharmaceuticals Inc (EYPT)
NASDAQ:EYPT
US Market

EyePoint Pharmaceuticals (EYPT) Income Statement

Compare
964 Followers

EyePoint Pharmaceuticals Income Statement

Last quarter (Q3 2025), EyePoint Pharmaceuticals's total revenue was $966.00K, a decrease of -90.82% from the same quarter last year. In Q3, EyePoint Pharmaceuticals's net income was $-59.73M. See EyePoint Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 43.27M$ 46.02M$ 41.40M$ 36.94M$ 34.44M
Gross Profit
$ 39.56M$ 41.39M$ 33.08M$ 28.76M$ 28.61M
Operating Expenses
$ 185.41M$ 116.45M$ 132.72M$ 84.04M$ 65.90M
Depreciation and Amortization
$ 1.54M$ 464.00K$ 2.45M$ 2.77M$ 2.65M
EBITDA
$ -129.23M$ -69.00M$ -96.62M$ -50.15M$ -35.49M
Operating Income
$ -145.85M$ -75.07M$ -99.64M$ -55.28M$ -37.29M
Other Income/Expenses
$ 15.07M$ 4.36M$ -2.62M$ -3.14M$ -8.10M
Pretax Income
$ -130.78M$ -70.71M$ -102.25M$ -58.42M$ -45.39M
Net Income
$ -130.87M$ -70.80M$ -102.25M$ -58.42M$ -45.39M
Per Share Metrics
Basic EPS
$ -2.32$ -1.82$ -2.74$ -2.03$ -3.54
Diluted EPS
$ -2.32$ -1.82$ -2.74$ -2.03$ -3.54
Weighted Average Shares Outstanding
56.30M 38.90M 37.32M 28.76M 12.84M
Weighted Average Shares Outstanding (Diluted)
56.30M 38.90M 37.32M 28.76M 12.84M
Currency in USD

EyePoint Pharmaceuticals Earnings and Revenue History